Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
About this item
Full title
Author / Creator
Dat’AIDS Study Group , for the Dat’AIDS Study Group , Gantner, Pierre , Cotte, Laurent , Allavena, Clotilde , Bani-Sadr, Firouzé , Huleux, Thomas , Duvivier, Claudine , Valantin, Marc-Antoine , Jacomet, Christine , Joly, Véronique , Chéret, Antoine , Pugliese, Pascal , Delobel, Pierre , Cabié, André and Rey, David
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Achieving functional cure of chronic HBV infection (Hepatitis B surface antigen [HBsAg] clearance, eventually followed by acquisition of anti-hepatitis B surface antigen [Anti-HBs]) in individuals with HIV and HBV infections is a rare event. In this setting, factors related to HBV cure have not yet been fully characterized.
HIV-infected individu...
Alternative Titles
Full title
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2211528053
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2211528053
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0215464
